Top 10 Leading Players in the Philippines Atherosclerosis Market | Competitive Landscape 2026

Philippines Atherosclerosis Market Overview

According to 6Wresearch, the Philippines atherosclerosis market is projected for significant expansion, driven by a growing elderly population and a high prevalence of lifestyle-related risk factors such as hypertension. Atherosclerosis is a primary driver of morbidity, which consistently ranks as the leading cause of death from heart diseases.

The market is shaped by government initiatives, that focus on the prevention of non-communicable diseases. Additionally, the key trends that shape the market include the development of Specialty Centres and the implementation of the PhilHealth Z-Benefit packages, which aim to make chronic management more accessible.

Competitive Landscape

The competitive landscape of the Philippines atherosclerosis industry is determined by the dominance of global biopharmaceutical giants along with a growing network of local manufacturing and distribution channels. Leading companies maintain an effective market share through extensive clinical data, brand trust, and strategic partnerships with hospital networks and retail pharmacies.

Below is a list of leading players operating in the Philippines Atherosclerosis Market:

1. United Laboratories, Inc. (Unilab)

Unilab is the dominant leader, known for its extensive range of affordable statins and high-quality cardiovascular maintenance medicines.

2. Pascual Laboratories, Inc.

Pascual Lab maintains a strong presence through its portfolio of cardiovascular solutions and a commitment to accessible healthcare.

3. Natrapharm, Inc.

The company focuses on metabolic and cardiovascular diseases, offering a wide range of specialized lipid-lowering treatments.

4. Getz Pharma (Philippines), Inc.

Getz Pharma is a leader in providing essential treatments for chronic conditions, particularly in the cardiovascular and metabolic segments.

5. Euro-Med Laboratories Phil., Inc.

Euro-Med provides essential pharmaceutical solutions and specialty products used in the clinical management of cardiovascular events.

6. Lloyd Laboratories, Inc.

Lloyd Laboratories is a key supplier of cardiovascular pharmaceuticals, known for its manufacturing excellence and supply of essential medicines.

7. Sanofi Philippines

Sanofi is involved in providing innovative therapies and specialty medicines that target various risk factors associated with atherosclerosis.

8. Novartis Healthcare Philippines, Inc.

Novartis contributes to the market with a focus on cutting-edge research in atherosclerotic cardiovascular disease.

9. AstraZeneca Philippines

AstraZeneca has a strong footprint, offering advanced global treatments for atherosclerosis and related cardiovascular complications.

10. Pfizer Philippines

Pfizer Philippines is a prominent global player providing widely recognized statin brands and innovative cardiovascular health solutions.